
James H. Derrington
Examiner (ID: 16771)
| Most Active Art Unit | 1307 |
| Art Unit(s) | 3202, 1307, 1731, 3303 |
| Total Applications | 1582 |
| Issued Applications | 1268 |
| Pending Applications | 46 |
| Abandoned Applications | 268 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18374233
[patent_doc_number] => 20230149310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => LIPID PARTICLES FOR NUCLEIC ACID DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/042848
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042848
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042848 | Lipid particles for nucleic acid delivery | Mar 31, 2019 | Issued |
Array
(
[id] => 14649545
[patent_doc_number] => 20190231901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR PAH GENE TRANSFER AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/369879
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16369879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/369879 | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof | Mar 28, 2019 | Issued |
Array
(
[id] => 14864861
[patent_doc_number] => 20190282672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => COMPOSITIONS AND METHODS FOR PROMOTING THE MINERALIZATION OF BIOLOGICAL TISSUE
[patent_app_type] => utility
[patent_app_number] => 16/368042
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/368042 | Compositions and methods for promoting the mineralization of biological tissue | Mar 27, 2019 | Issued |
Array
(
[id] => 16581462
[patent_doc_number] => 20210015864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => CHIMERIC TRANSMEMBRANE PROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/040009
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040009 | Chimeric transmembrane proteins and uses thereof | Mar 20, 2019 | Issued |
Array
(
[id] => 14930531
[patent_doc_number] => 20190300903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF DUX4
[patent_app_type] => utility
[patent_app_number] => 16/299456
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299456 | Recombinant virus products and methods for inhibition of expression of DUX4 | Mar 11, 2019 | Issued |
Array
(
[id] => 16655987
[patent_doc_number] => 20210052623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => LIQUID COMPOSITION CONTAINING HIGH CONCENTRATION OF DNA FRAGMENT MIXTURE AND HAVING FLUIDITY AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/979049
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979049
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979049 | LIQUID COMPOSITION CONTAINING HIGH CONCENTRATION OF DNA FRAGMENT MIXTURE AND HAVING FLUIDITY AND PREPARATION METHOD THEREFOR | Mar 6, 2019 | Abandoned |
Array
(
[id] => 17020956
[patent_doc_number] => 20210244827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/256812
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256812 | ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS | Mar 6, 2019 | Pending |
Array
(
[id] => 16539499
[patent_doc_number] => 20200405912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => DECELLULARIZED BONE BIOMATERIAL ENRICHED WITH A HYDROGEL CONTAINING DECELLULARIZED EXTRACELLULAR BONE MATRIX
[patent_app_type] => utility
[patent_app_number] => 16/976052
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976052 | DECELLULARIZED BONE BIOMATERIAL ENRICHED WITH A HYDROGEL CONTAINING DECELLULARIZED EXTRACELLULAR BONE MATRIX | Feb 25, 2019 | Abandoned |
Array
(
[id] => 16246112
[patent_doc_number] => 10745453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Compositions and methods for enhancing visual function
[patent_app_type] => utility
[patent_app_number] => 16/279576
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24399
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279576 | Compositions and methods for enhancing visual function | Feb 18, 2019 | Issued |
Array
(
[id] => 16619993
[patent_doc_number] => 20210038646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => CHIMERIC ANTIGEN RECEPTORS TARGETING THE TUMOR MICROENVIRONMENT
[patent_app_type] => utility
[patent_app_number] => 16/969098
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -146
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969098
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969098 | CHIMERIC ANTIGEN RECEPTORS TARGETING THE TUMOR MICROENVIRONMENT | Feb 11, 2019 | Pending |
Array
(
[id] => 19916350
[patent_doc_number] => 12291706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Methods for screening variant of target gene
[patent_app_type] => utility
[patent_app_number] => 16/968602
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 3478
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968602
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968602 | Methods for screening variant of target gene | Feb 7, 2019 | Issued |
Array
(
[id] => 16612145
[patent_doc_number] => 20210030798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => CHIMERIC RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/967377
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967377 | CHIMERIC RECEPTOR | Feb 3, 2019 | Abandoned |
Array
(
[id] => 16620091
[patent_doc_number] => 20210038744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR VIII
[patent_app_type] => utility
[patent_app_number] => 16/965895
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 410
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965895 | USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR VIII | Jan 30, 2019 | Pending |
Array
(
[id] => 14227397
[patent_doc_number] => 20190125871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => DEVICES, SYSTEMS AND METHODS FOR OPTOGENETIC MODULATION OF ACTION POTENTIALS IN TARGET CELLS
[patent_app_type] => utility
[patent_app_number] => 16/241763
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -110
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241763 | DEVICES, SYSTEMS AND METHODS FOR OPTOGENETIC MODULATION OF ACTION POTENTIALS IN TARGET CELLS | Jan 6, 2019 | Abandoned |
Array
(
[id] => 14682471
[patent_doc_number] => 20190240350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => Vectors for Liver-Directed Gene Therapy of Hemophilia and Methods and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/229491
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229491
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/229491 | Vectors for liver-directed gene therapy of hemophilia and methods and use thereof | Dec 20, 2018 | Issued |
Array
(
[id] => 14501303
[patent_doc_number] => 20190194306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => COMPOSITIONS FOR DIAGNOSIS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT EXPRESSION OF FUTRINS (R-SPONDINS) AND/OR WNT
[patent_app_type] => utility
[patent_app_number] => 16/224230
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/224230 | COMPOSITIONS FOR DIAGNOSIS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT EXPRESSION OF FUTRINS (R-SPONDINS) AND/OR WNT | Dec 17, 2018 | Abandoned |
Array
(
[id] => 14468339
[patent_doc_number] => 20190185812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => METHOD OF DIFFERENTIATING NEURAL STEM CELLS OR NEURAL PRECURSOR CELLS INTO DOPAMINE NEURONS
[patent_app_type] => utility
[patent_app_number] => 16/220048
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220048
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/220048 | METHOD OF DIFFERENTIATING NEURAL STEM CELLS OR NEURAL PRECURSOR CELLS INTO DOPAMINE NEURONS | Dec 13, 2018 | Abandoned |
Array
(
[id] => 14625237
[patent_doc_number] => 20190225986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/206258
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16206258
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/206258 | GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN | Nov 29, 2018 | Abandoned |
Array
(
[id] => 14231171
[patent_doc_number] => 20190127758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => PRODUCTION OF VIRAL VECTORS
[patent_app_type] => utility
[patent_app_number] => 16/183393
[patent_app_country] => US
[patent_app_date] => 2018-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16183393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/183393 | PRODUCTION OF VIRAL VECTORS | Nov 6, 2018 | Abandoned |
Array
(
[id] => 16901175
[patent_doc_number] => 20210180091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 16/758990
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -124
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758990 | MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES | Oct 25, 2018 | Pending |